Trial reportJACC. Cardiovascular imaging2021
CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.
Trial report in JACC. Cardiovascular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07192965 (ECG-less Coronary Computed Tomography Angiography in the Management of Patients Presenting With High-troponin Chest Pain), which is not on this map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
ECG-less Coronary Computed Tomography Angiography in the Management of Patients Presenting With High-troponin Chest Pain
Who cites it
40 citing papers in PubMed.
- Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.Circulation · 2025Trial
- Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.Circulation. Cardiovascular quality and outcomes · 2025Trial
- Evaluation of the clinical value of CCTA as the preferred screening method in patients with chronic coronary syndrome.BMC cardiovascular disorders · 2025Trial
- Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.Circulation. Cardiovascular interventions · 2024Trial
- Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.European heart journal · 2024Trial
- Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial.JACC. Cardiovascular imaging · 2023Trial
- Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial.Circulation. Cardiovascular interventions · 2022Trial
- Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial.Journal of the American College of Cardiology · 2022Trial
- Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.Circulation · 2021Trial
- Fragmented QRS on Baseline Electrocardiography Predicts Anatomically Significant Stenosis in Patients With Intermediate Coronary Lesions on Coronary Computed Tomography Angiography.Cardiology research · 2026Article
- Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary disease.Nature communications · 2026Article
- Improving Stress Echocardiography for Enhanced Detection of Left Main and Multivessel Coronary Artery Disease.CJC open · 2026Article
- Assessment of non-alcoholic fatty liver disease in suspected coronary artery disease patients: prognostic value and incremental predictive utility over cardiovascular risk factors and CCTA.BMC medical imaging · 2025Article
- The role of cardiac imaging in the post-ISCHEMIA world.The British journal of radiology · 2025Review
- Coronary Computed Tomographic Angiography to Optimize the Diagnostic Yield of Invasive Angiography for Low-Risk Patients Screened With Artificial Intelligence: Protocol for the CarDIA-AI Randomized Controlled Trial.JMIR research protocols · 2025Article
- Predictors of Diagnostic Inaccuracy of Detecting Coronary Artery Stenosis by Preprocedural CT Angiography in Patients Prior to Transcatheter Aortic Valve Implantation.Diagnostics (Basel, Switzerland) · 2025Article
- Real-world application of CCTA with CT-FFR for coronary assessment pre-TAVI: the CT2TAVI study.The international journal of cardiovascular imaging · 2025Observational
- Prediction of obstructive coronary artery disease in people living with HIV: value of machine learning incorporating HIV-specific factors.Frontiers in medicine · 2025Article
- Super-resolution deep-learning reconstruction for cardiac CT: impact of radiation dose and focal spot size on task-based image quality.Physical and engineering sciences in medicine · 2024Article
- Concordance between Coronary Artery Computed Tomography and Invasive Coronary Angiography in a Real-World Population with Suspected Chronic Coronary Syndrome.Diagnostics (Basel, Switzerland) · 2024Article
Corrections and comments
- Commented on by
- Erratum issuedCorrection.2021
Authors and funding
21 authors.
Funding
Abstract
objectivesThis study aimed to examine the concordance of coronary computed tomographic angiography (CCTA) assessment of coronary anatomy and invasive coronary angiography (ICA) as the reference standard in patients enrolled in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches).
backgroundPerformance of CCTA compared with ICA has not been assessed in patients with very high burdens of stress-induced ischemia and a high likelihood of anatomically significant coronary artery disease (CAD). A blinded CCTA was performed after enrollment to exclude patients with left main (LM) disease or no obstructive CAD before randomization to an initial conservative or invasive strategy, the latter guided by ICA and optimal revascularization.
methodsRates of concordance were calculated on a per-patient basis in patients randomized to the invasive strategy. Anatomic significance was defined as ≥50% diameter stenosis (DS) for both modalities. Sensitivity analyses using a threshold of ≥70% DS for CCTA or considering only CCTA images of good-to-excellent quality were performed.
resultsIn 1,728 patients identified by CCTA as having no LM disease ≥50% and at least single-vessel CAD, ICA confirmed 97.1% without LM disease ≥50%, 92.2% with at least single-vessel CAD and no LM disease ≥50%, and only 4.9% without anatomically significant CAD. Results using a ≥70% DS threshold or only CCTA of good-to-excellent quality showed similar overall performance.
conclusionsCCTA before randomization in ISCHEMIA demonstrated high concordance with subsequent ICA for identification of patients with angiographically significant disease without LM disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.